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1. Introduction 
In the currently accepted model of the thrombin 
(EC 3.4.21.5)-induced fibrinogen/fibrin conversion 
[1-3] the initial step consists of the splitting.off of 
2 fibrinopeptides A from the Ate-chains of fibrinogen, 
followed by the linear polymerization f the fibrin 
monomers to yield protofibrils. The subsequent release 
of fibrinopeptide B from these protofibrils i  assumed 
to lead to the formation of fibers through lateral 
aggregation. In a final step, fibers are linked to form 
the three-dimensional dot. 
In the following we shall restrict ourselves to the 
earliest stages of the polymerization, effected by the 
release of only fibrinopeptide A.
In a remarkable gel-fdtration study Smith [4] 
observed that the thrombin-induced polymerization 
of fibrin at pH 7.4 and ionic strengths of 0.36 and 
0.21 M can be instantly stopped by the addition of 
the thrombin-inhibitor hi udin [5]. To explain the 
inhibitory effect it was proposed that under these 
experimental conditions only peptide A is released 
and that the polymerization proceeds via the rapid 
self-associations of monofunctional, monomeric and 
polymeric intermediates [4] (see fig.l). 
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Fig.1. Polymerization scheme for monofunctional fibrins 
according to [41. P] and P; stand for the inactive and active 
/'-fold aggregates, respectively, whereas E stands for the enzyme. 
Here, we confirm the observation of the inhibitory 
effect of hirudin by light scattering measurements 
[4]. Moreover, we developed a steady-state kinetic 
model of the polymerization, which allows us to relate 
the progress of the weight-average Mr, as obtained 
from light scattering, to the degree of release of 
fibrinopeptide A.
2. Experimental methods and results 
Human fibrinogen was purified as in [6] with an 
additional DEAE-purification step to remove high 
M r material. Purity was checked by SDS-PAGE. 
Thrombin was lot no. 0056296 from Merck of 50 
NIH-units/mg. Hirudin, grade IV, was from Sigma 
(St Louis Me). 
Thrombin activity, Ea, was estimated at 405 nm 
and 37°C from the rate of splitting of H-D-Phenyl- 
alanyl- L-pipecolyl- L-at ginine-p-nitroanalide dihy- 
drochloride (S-2238 from Kabi). 
Light scattering was measured at 633 nm with an 
instrument developed in this laboratory by Vreeman 
and Van Markwijk. After mixing enzyme and substrate 
the intensity of the scattered light was measured 
almost instantaneously at 9 angles at different reac- 
tion times and extrapolated tozero scattering angle 
to obtain the reciprocal apparent weight-av. Mr (fig.2). 
The data were then recalculated to obtain the plot of 
the apparent weight-av. Mr (Mr-app.) as a function of 
time. It can be shown (A. V., in preparation) that 
under the present experimental conditions these app. 
Mr-Values closely approximate he true weight-average. 
Some typical M r growth curves at 0.5 M NaCI, 
0.05 M Tris (pH 7.4) and 20°C are collected in fig.3. 
Under these experimental conditions the progress of 
the weight-av. Mr is approximately sigmoidal. More- 
over the experiment a E a = 35.5 X 10 -3 . rain -1 
Published by Elsevier Biomedical Press 
00145793/82/0000-0000/$02.75 © 1982 Federation of European Biochemical Societies 35 
Volume 142, number 1 FEBS LETTERS June 1982 
Kc/AR(O) 3.5- 
(rnol/¢ 
2.8 
2 . ]  
].4 
O.? 
x 10 "6 
":5:::::" 
*" ÷.  ** 
2:: :" 
0 60 120 180 240 
t ÷ ksin g Or2 (rain) 
Fig.2. Time- and angle-dependency of the quantity Kc/AR(O), 
where K is Rayleigh's constant, c fibrinogen concentration 
and AR(0) the excess cattering at angle 0. ([]) Extrapolated 
reciprocal apparent weight-av. Mr at zero angle (of. [11 ]). 
Experimental conditions: 0.5 M NaC1, 0.05 M Tris (pH 7.4) 
and 20°C. Fibrinogen was 0.556 mg]ml; thrombin act. 
15.4 × 10 -3. min -l. 
demonstrates that hirudin indeed is able to completely 
inhibit polymerization, as originally observed in [4]. 
Similar inhibitions have been observed at the lower 
ionic strengths of 0.35 and 0.15 M. 
Parallel to the light-scattering measurements the 
release of fibrinopeptides A and B was followed by 
HPLC. To this end, at different reaction times 200/A 
samples were drawn from the reaction mixture in the 
light-scattering cuvet and heated at 90°C for 2 min to 
deactivate thrombin and to precipitate fibrinogen and 
fibrin [7]. After centrifugation, 70 pl of he super- 
natant was injected on a 3.9 mm × 30 cm tam 
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Fig. 3. Some typical progress curves for the thrombin-induced 
polymerization f fibrin. Experimental conditions: 0.5 M 
NaC1, 0.05 M Tris (pH 7.4). Fibrinogen: (a) 0.803 mg/ml; 
(*) 0.660 mg/ml; (+) 0.473 mg/ml. Thrombin act.: (a) 
3.80 × 10 -s. min-l; (o) 18.7 × 10 "3. min-t; (+) 35.5 X 
10 -3 . min-l; (,) indicates the moment of hirudin addition. 
Bondapak Cts column (Waters Assoc.). Separation of 
the fibrinopeptides was satisfactory with an eluent 
consisting of 80% 0.01 M ammonium phosphate 
(pH 2.90) and 20% acetonitrile [8] at a flow rate of 
2 ml/min. 
3. Discussion 
The finding that hirudin is able to instantly inhibit 
the polymerization of fibrin implies that under the 
prevailing experimental conditions the kinetics of the 
process is completely enzyme-controlled. In [41 it 
was suggested that at the relatively high ionic strengths 
as used here, the rate of proteolysis is the rate-deter- 
mining step in the enzymatic fibrinogen]fibrin con- 
version. As a consequence, fibrin monomers with just 
one A-peptide split off, rapidly dimerize with other 
monofunctional monomers to form a blocked dimer. 
Dimers in turn can be activated by the splitting off of 
a further A-peptide to yield the activated, monofunc- 
tional dimer. These rapidly form inert trimers and 
tetramers through associations with other activated 
monofunetional monomers and dimers, and so on 
(see rigA). This reaction scheme does not contradict 
those proposed in [3,91. 
The rate equations for the above reaction scheme 
read: 
d[Pa]/dt = -v ' [Pa]  (1) 
] -1  
dIP/l/dt = -v ' [P/ ]  + (ks/2) i~l  [P/*-i] [P*] 
j = 2,3,4 ...... (2) 
and 
d[P~l/dt = v'tP/] - kstP~] i~1 [P~} 
/= 1,2,3,. ... (3) 
where: 
[P/] = the number concentrations of the inert species 
of the degree of polymerization ]; 
[P/*] = that of the corresponding monofunctional 
species; 
k s = a universal association constant. 
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The factor 1/2 in the second term on the right side of 
eq. (2) is introduced to avoid double counting of 
aggregated species [10]. Further, equal substrate prop- 
erties are accepted for monomerie and polymeric 
Pi-particles. In agreement with this assumption v'in 
eq. (1)-(3)is defined by: 
v =Vma x m (4) 
with K m the Michaelis-Menten constant. 
The hirudin experiment demonstrates that the 
polymerization instantly stops after the addition of 
the inhibitor, and that therefore the concentrations 
of activated species, [P/*], must be vanishingly ow. 
Introducing the steady-state condition d[P/*] [dt = 0 
into eq. (3) then immediately leads to the following 
set of equations for the rate of change of inert particles: 
'N~ "k, 
d Y. [P/]/dt=(v'/2) ~ [P/] (5) 
1=1 j= l  
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Fig.4. Comparing the progress of the weight-average M r of 
polymerizing fibrin to the rate of fibrinopeptide-A release. 
Experimental conditions: 0.5 M NaCI, 0.05 M Tris (pH 7.4) 
and 20°C. Fibrino_~n: 0.337 mg/ml; thrombin act. 2.17 × 
10 -3 . min -a. (e) (M r - Ma)/(M r +Mr) as measured bylight 
scattering; (,) and (+), release of fibrinopeptide A and B, 
respectively. 
in which a is the degree of fibrinopeptide A release, 
defined as: 
d[P/]/dt=-v'[Pi] +(v'/2)/~1i=1 [Pj-i] [Pi]//--ZI [P/] 
'Xs 
a= Z 2(/-1) [P/I/2[P °] (10) 
/=i 
j = 2,3,4 ...... 05) 
Equation (6) can be integrated to yield: 
[PJ]/(/=~I [P/] 2= -]=1 Y~ tP/]/[P°] /-1/[P°] 
(7) 
in which [pO] is the number concentration ffibrinogen 
"k, 
at the start of the reaction and Z [P/] can be cal- 
/=1 
culated from the integrated eq. (5). 
The weight-av. M r is defined by (11): 
~tr=M 1 Z /2 /=1 [P/]/~1/[P/] (8) 
where: Ml = M r of the monomer 
Inserting eq. (7) into eq. (8) and carrying through 
the summation f'mally gives: 
Mr~M, = (1 + ~) /0  - ~) (9) 
Eq. (9) allows the independent measurements of 
the growth of the weight-av. Mr and the release of 
fibrinopeptide Ato be compared. As riga shows, there 
is indeed a fair correspondance of the plots of 
(M r - MI )/(M r +MI) (eq. (9)) and the degree of pep- 
tide A release as measured by HPLC. This observation 
gives support o the polymerization scheme originally 
proposed in [4], this the more so since it is seen that 
the release of fibrinopeptide B strongly falls behind 
that of peptide A. 
Deviations are currently investigated in terms of 
fibrinogen/fibrin complex formation, non-ideality 
effects and the influence of the small release of pep- 
tide B on the functionality of the aggregating species. 
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